AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.

Research and Markets: prostate cancer - UK drug forecasts and treatment analysis to 2020.

Chemical Business Newsbase

| November 23, 2010 | COPYRIGHT 2000 Elsevier Engineering Information, Inc. (Hide copyright information)Copyright

Research and Markets has announced the addition of GlobalData's new report Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020 to their offering. Prostate Cancer - UK Drug Forecasts and Treatment Analysis to 2020 is an essential source of information and analysis on the UK prostate cancer therapeutics market. The report provides comprehensive information on prostate cancer, highlighting the treatment guidelines. It identifies and analyzes the key trends shaping and driving the UK prostate cancer therapeutics market, and analyzes the treatment usage patterns. The report also provides insights into the competitive landscape and the emerging players expected to significantly …

Related articles from newspapers, magazines, journals, and more
PRESS RELEASE: GTx preventive drug for prostate cancer begins next phase of...
News wire article from: Chemical Business Newsbase October 31, 2001 700+ words
Clinical Trials for Prostate Cancer.
Newspaper article from: Harvard Men's Health Watch March 1, 2002 700+ words
Cell Genesys to present data from Gvax prostate cancer and myeloma vaccine...
News wire article from: Asia Africa Intelligence Wire April 2, 2003 700+ words
Ipilimumab (MDX-010) shows encouraging data in Phase I and Phase II clinical...
News wire article from: Chemical Business Newsbase June 5, 2006 700+ words
(AEPGL) Progen expands PI-88 clinical trials to prostate cancer.
News wire article from: Asia Africa Intelligence Wire August 9, 2005 700+ words
©2013 Gale, a part of Cengage Learning. All rights reserved. Contact us | Privacy policy | Terms and conditions

The AccessMyLibrary advertising network includes: womensforum.com GlamFamily